Analytical Diagnostic Labs, Inc. v. Kusel

626 F.3d 135, 2010 U.S. App. LEXIS 20422, 2010 WL 3835087
CourtCourt of Appeals for the Second Circuit
DecidedOctober 4, 2010
DocketDocket 08-6297-cv
StatusPublished
Cited by105 cases

This text of 626 F.3d 135 (Analytical Diagnostic Labs, Inc. v. Kusel) is published on Counsel Stack Legal Research, covering Court of Appeals for the Second Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Analytical Diagnostic Labs, Inc. v. Kusel, 626 F.3d 135, 2010 U.S. App. LEXIS 20422, 2010 WL 3835087 (2d Cir. 2010).

Opinion

POOLER, Circuit Judge:

This case presents a class-of-one equal protection claim by plaintiff Analytical Diagnostic Labs, Inc. (“ADL”). ADL alleges that defendants — employees of the New York State Department of Health (“DOH”) — intentionally and maliciously subjected ADL to an intense and unwarranted degree of regulatory scrutiny. ADL appeals from the September 11, 2008 memorandum decision and order of the United States District Court for the Eastern District of New York (Cogan, /.). The district court, relying on the Supreme Court’s decision in Engquist v. Oregon Dep’t of Agriculture, 553 U.S. 591, 128 S.Ct. 2146, 170 L.Ed.2d 975 (2008), found ADL’s claims barred because ADL could not show the alleged differential treatment resulted from non-discretionary state action. We find the district court’s reading of Engquist overbroad and reverse that part of the opinion. We also disagree with the district court’s conclusion that ADL presented sufficient evidence to demonstrate it was treated differently from other similarly situated entities. We therefore affirm the grant of summary judgment, albeit on different grounds.

BACKGROUND

ADL is a privately owned clinical testing laboratory that serves nursing homes and similar facilities in the New York City area. It is regulated by DOH, and New York state law requires that all clinical laboratories obtain permits annually to continue operating. N.Y. Pub. Health §§ 574-75. Permits are issued only upon a DOH finding that the laboratory is “competently staffed and properly equipped, and will be operated in the manner” required by law. N.Y. Pub. Health § 575(2). Permits cannot issue until “the laboratory has been inspected and has corrected any deficiencies found.” 10 N.Y. Comp.Codes R. & Regs. § 58-l.l(a)(2). In addition, a lab may hold a permit to perform a given category of testing only if the laboratory director holds a certificate of qualification (“CQ”) in that category of testing. N.Y. Pub. Health §§ 572, 575(2). CQs are granted for initial terms of two years, and may be renewed for subsequent two-year terms.

ADL began operating approximately 20 years ago, and until 2000, ADL passed its DOH inspections without major deficiencies being noted. In July 2000, the DOH began conducting far more frequent surveys of ADL, as often as every six months, which DOH asserted was necessary because of the number of deficiencies found at the laboratory and ADL’s failure to implement a plan of correction.

In late 2003, DOH began investigating allegations that ADL was illegally performing forensic toxicology. ADL did perform some toxicology testing for at least one of its clients, but its laboratory reports clearly stated that specimen analysis was performed without any chain-of-custody handling, and thus test results were not to be used for legal or evaluation purposes. ADL alleges other laboratories, including Quest Diagnostics and LabCorp, used nearly identical disclaimers on similar toxicology testing. DOH brought charges against ADL for improper forensic testing in 2005. Those charges were settled, with ADL admitting no wrongdoing but paying a $3,000 civil penalty.

DOH’s in-depth scrutiny of ADL continued from 2004 through 2007. Defendant Betty Kusel, director of regulatory affairs at DOH, scheduled numerous surveys and investigations of ADL. Kusel deliberately scheduled at least two of these investigations to fall on Jewish holidays, when she *138 knew ADL’s principals, observant Jews, would be out of the office. Kusel told defendant Stephanie Shulman that the absence of ADL’s principals would give DOH an opportunity to search for specific paperwork.

On August 2, 2006 — the eve of a Jewish holiday — DOH employees arrived at ADL unannounced and stationed an investigator at a side entrance with a video camera, “in hopes of capturing any fleeing' personnel.” DOH investigators also questioned Pakistani-born ADL employees about their citizenship and immigration status, and whether their families were legally in the United States.

During the same time period, DOH refused to renew ADL’s operating permit, instead issuing a series of letters under the State Administrative Procedure Act (“SAPA”). These letters functioned in lieu of an operating permit. ADL’s lab directors also began experiencing problems with renewals of their CQs.

In August, 2004, Dr. Kumaranayagam Balakrishnan, ADL’s longtime lab director, submitted a renewal application for his CQ. Kusel advised him that his CQ renewal was being delayed because of the ongoing forensic investigation. In March 2006, DOH threatened to charge Dr. Balakrishnan personally for illegal forensic testing, even though ADL already had settled those charges. Dr. Balakrishnan resigned from ADL in April 2006. Even after his resignation, he faced trouble renewing his CQ. An August 22, 2006 email from Kusel to a DOH staffer stated that Dr. Balakrishnan had two choices: “admit to not fulfilling duties as a director because he is incompetent or unwilling to comply ... [or] he can fall on our mercies that the owners of ADL did not allow him to fulfill his duties — at which point we may be willing to show some leniency.” On December 4, 2006, Kusel emailed another DOH staffer, stating that she would be willing to “settle the old charges and issue a CQ that would be very close to expiring ... it would be more of a nice surprise when he’s included in the ADL charges.”

After Dr. Balakrishnan’s departure, ADL experienced significant trouble hiring and retaining a lab director. Drs. George Abraham and Matthew Pincus began working there in May and June 2006, respectively. The doctors prepared and submitted a plan of correction to the DOH. After a conversation with defendant Dr. Richard W. Jenny in which Dr. Jenny threatened that any failure to correct the laboratory’s problems could negatively impact Dr. Pincus’ CQ, Dr. Pincus resigned as laboratory director in August 2006.

ADL then hired Dr. Ming Liu to serve as an assistant laboratory director to Dr. Abraham. Shortly after, defendant Deirdre Astin sent Dr. Liu a letter questioning whether he could devote the necessary time to ADL, given that he already held other positions at other facilities. In that same letter, Astin told Dr. Liu that DOH would not approve any director at ADL unless that director could be on the premises of the laboratory for at least 50 percent of its operating hours because of the laboratory’s “significant compliance issues.” As Dr. Abraham did not hold a CQ in various testing categories, DOH voided ADL’s operating permit and directed ADL to cease testing in those categories. On September 28, 2006, Dr. Liu resigned.

On the same day as Dr. Liu’s resignation, a DOH supervisor visited ADL and found the laboratory had corrected all pri- or deficiencies and found no significant new problems. DOH never conveyed the results of the surveyor’s visit to ADL.

ADL then hired Dr. Lilia Mesia as its laboratory director and Dr. Henry Gang as assistant director in October 2006. Be *139 cause Dr. Mesia possessed the required CQ’s, DOH issued a SAPA letter authorizing ADL to resume testing in all areas except one, since Dr. Abraham indicated the laboratory was not ready to resume testing in that area. In January 2007, Dr. Mesia moved out of state, so ADL hired Dr. Joel Lincoln as director. In September 2007, Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
626 F.3d 135, 2010 U.S. App. LEXIS 20422, 2010 WL 3835087, Counsel Stack Legal Research, https://law.counselstack.com/opinion/analytical-diagnostic-labs-inc-v-kusel-ca2-2010.